Johnson & Johnson reports response rate for head, neck cancer treatment

JNJ's Rybrevant Faspro combination therapy shows a positive response with 77% tumor shrinkage in the early clinical trial of progressive head and neck cancer.

View Source Article ↗

AI CATALYST SCORE68 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

ANALYSIS HISTORY

JNJ Analysis History (Last 30 Days)

Diagnosed At	Ticker	AI Score	Tier
2026-10-25 21:56:56	JNJ	68	Mid	View Report →
2026-10-19 12:13:11	JNJ	68	Mid	View Report →
2026-10-13 20:49:41	JNJ	82	Mid	View Report →

RELATED REPORTS

Related Theme Reports #healthcare

Diagnosed At	Ticker	AI Score	Tier
2026-10-25 23:04:05	LLY	78	Mid	View Report →
2026-10-25 19:20:42	SGRY	80	Mid	View Report →
2026-10-25 18:43:11	SMMT	85	Mid	View Report →
2026-10-25 13:29:37	MEDP	35	Row	View Report →
2026-10-25 12:05:03	MRNA	45	Mid	View Report →
2026-10-24 17:51:34	PFE	62	Mid	View Report →
2026-10-24 15:37:02	PFE	55	Mid	View Report →
2026-10-24 14:16:22	LLY	65	Mid	View Report →
2026-10-24 12:28:05	MRNA	65	Mid	View Report →
2026-10-23 21:17:52	CPIX	45	Mid	View Report →
2026-10-23 19:02:09	MRNA	50	Mid	View Report →
2026-10-23 18:27:45	SNN	42	Row	View Report →
2026-10-23 18:03:09	BCPC	45	Mid	View Report →
2026-10-23 16:30:29	MRNA	60	Mid	View Report →
2026-10-23 16:28:06	CVS	45	Mid	View Report →
2026-10-23 16:00:41	MRNA	45	Mid	View Report →
2026-10-23 09:05:25	MRNA	25	Row	View Report →
2026-10-23 03:26:58	KMTS	35	Row	View Report →
2026-10-22 21:53:58	MRNA	50	Mid	View Report →
2026-10-22 21:05:36	MOH	62	Mid	View Report →
2026-10-22 19:42:35	MRNA	45	Mid	View Report →
2026-10-22 17:39:22	MRNA	45	Mid	View Report →
2026-10-22 15:17:00	MRNA	55	Mid	View Report →
2026-10-22 02:29:00	QGEN	35	Row	View Report →
2026-10-21 22:17:32	MEDP	75	S-Class	View Report →
2026-10-21 21:47:44	MOH	45	Mid	View Report →
2026-10-21 21:07:15	MEDP	55	Mid	View Report →
2026-10-21 20:06:40	QGEN	78	Mid	View Report →
2026-10-21 17:13:52	DGX	25	Row	View Report →
2026-10-21 16:35:14	ELV	85	S-Class	View Report →

View Full History for JNJ (Blueprint) →